REPRO-MED Systems Holds Annual Shareholder Meeting

An announcement from REPRO-MED Systems ( (KRMD) ) is now available.

On May 14, 2025, REPRO-MED Systems held its Annual Meeting of Shareholders where key decisions were made regarding the company’s governance and financial oversight. Shareholders elected the proposed nominees to the board of directors, approved executive compensation on an advisory basis, and ratified the appointment of Cherry Bekaert LLP as the independent registered public accountants for the 2025 fiscal year.

The most recent analyst rating on (KRMD) stock is a Hold with a $4.50 price target. To see the full list of analyst forecasts on REPRO-MED Systems stock, see the KRMD Stock Forecast page.

Spark’s Take on KRMD Stock

According to Spark, TipRanks’ AI Analyst, KRMD is a Neutral.

KORU Medical Systems (KRMD) demonstrates promising growth potential with strong revenue increases and strategic expansion in core and international markets. However, the company’s persistent financial losses and negative cash flow present significant challenges that weigh heavily on its overall stock score. While short-term technical indicators show some positive momentum, valuation metrics are concerning due to the lack of profitability. The raised revenue guidance and positive sentiment from the recent earnings call provide a supportive outlook, yet the company needs to effectively manage operational inefficiencies to bolster its financial health.

To see Spark’s full report on KRMD stock, click here.

More about REPRO-MED Systems

Average Trading Volume: 159,459

Technical Sentiment Signal: Buy

Current Market Cap: $148.1M

Learn more about KRMD stock on TipRanks’ Stock Analysis page.